摘要
目的探讨经尿道前列腺等离子体双极电切术(TUPKRP)治疗良性前列腺增生(BPH)的疗效。方法采用德国BOWA双极等离子体工作站行TUPKRP治疗BPH62例,按照ROUS标准:Ⅱ度21例,Ⅲ度28例,Ⅳ度13例。观察术中出血量、手术时间、留置尿管时间、住院时间以及手术并发症,比较术前后生活质量评分(QOL)、剩余尿量(RU)、国际前列腺症状评分(IPSS)的差异。结果术中出血量20～240ml,平均61.3ml。手术时间20～190min,平均53.2min;无膀胱穿孔和电切综合征等并发症出现。留置尿管4～9d,住院平均时间6.5d。所有患者随访3～24个月,QOL由(4.2±1.0)分下降至(2.2±0.7)分(t=99.037,P<0.001),IPSS由(23.3±5.6)分下降至(8.5±4.4)分(t=180.192,P<0.001),RU由(72.5±33.5)ml减少至(27.5±15.4)ml(t=40.829,P<0.001)。结论 TUPKRP治疗BPH,具有安全、并发症少、疗效确切等优点。
Objective To evaluate the clinical efficacy of the bipolar plasmakinetic transurethral resection of the prostate （TUPKRP） in the treatment of benign prostatic hyperplasia （BPH）. Methods Sixty-two cases of BPH treated with TUPKRP were reviewed retrospectively. According to ROUS standard, there were BPH grade H in 21 cases, grade m in 28 cases, grade IV in 13 cases. The operation time, the surgery blood loss, catherization time, trans- urethal resection syndrome （TURS） occurring, length of hospital stay, the difference of IPSS, quality of life （QOL） and residual urine （RU） volume were observed. Results Operation time ranged from 20 to 190 minutes, 53.2 min- utes in average. Surgery blood loss was 20--240 ml, 61.3 ml in average. There was no TURS and bladder rupture occurred. The catheter time was maintained for 4-9 days postoperatively. The average length of hospital stay was 6.5 days. All cases were followed up from 3 to 24 months. The IPSS decreased from （23.3±5.6） to （8.5±4.4）, r=180.192, P〈0.001. The QOL decreased from （4.2±1.0） to （2.2±0.7）, t=99.037, P〈0.001. The RU volume decreased from （72.5±33.5） ml to （27.5±15.4） ml, t=40.829, P〈0.001. Conclusion TUPKRP in the treatment of benign prostatic hyperpla- sia has advantages of high safety, less complications and satisfactory efficacy.
出处
《海南医学》
CAS
2013年第14期2112-2114,共3页
Hainan Medical Journal
关键词
良性前列腺增生症
经尿道前列腺电切术
等离子体双极
Benign prostatic hyperplasia
Transurethral resection of the prostate
Bipolar plasmakinetic
